Condition

Diabesity

ClinicalTrials.gov condition label

Clinical trials3

Recruiting2

Common interventions5

Lead sponsors shown2

Clinical trials

3 shown

Hong Kong Diabesity Register & 3-Year Trial on Integrated Care for Chinese With DiabesityNCT07039279 · 2025-10-22

Establishment of Hong Kong Diabesity RegisterNCT07247409 · 2025-10-22

Randomisation to Endobarrier Alone Versus With Incretin Analogue in SustainEd Diabesity (REVISE-Diabesity)NCT02055014 · 2013-07-01

Common interventions

Duodenal-jejunal bypass liner - Endobarrier deviceDEVICE1 LiraglutideDRUG1 Multicomponent Integrated Care ProgramBEHAVIORAL1 No Intervention: Observational CohortOTHER1 TourHeart + platformOTHER1

Leading sponsors

Chinese University of Hong Kong2 Sandwell & West Birmingham Hospitals NHS Trust1

Trial status mix

RECRUITING2

UNKNOWN1

Phase mix

NA1

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.